Skip to content
AminoWire

AminoWire

News in the World of Peptides

Advertisement
  • Home
FDA Broadens Offensive Against Online Peptide Vendors, Hitting NuScience Peptides Over Pipeline Weight-Loss Injections
Regulation & Policy

FDA Broadens Offensive Against Online Peptide Vendors, Hitting NuScience Peptides Over Pipeline Weight-Loss Injections

October 5, 2026October 5, 2026

WASHINGTON — In its third coordinated warning on the same day, the U.S. Food and Drug Administration has […]

FDA Fires Another Warning Shot at Online Peptide Sellers, Targeting Royal Peptides Over Unapproved Weight-Loss and Incretin Drugs
Regulation & Policy

FDA Fires Another Warning Shot at Online Peptide Sellers, Targeting Royal Peptides Over Unapproved Weight-Loss and Incretin Drugs

October 5, 2026October 5, 2026

WASHINGTON — In an expanding federal sweep against the direct-to-consumer peptide market, the U.S. Food and Drug Administration […]

FDA Targets Another Online Peptide Seller Over Illegal Weight-Loss Injections and ‘Research Only’ Claims
Regulation & Policy

FDA Targets Another Online Peptide Seller Over Illegal Weight-Loss Injections and ‘Research Only’ Claims

October 5, 2026October 5, 2026

U.S. Food and Drug Administration flagged online seller Felicia Romero, operator of texpeptide.com, over the unlawful distribution of several high-profile injectable drugs.

Recent Posts

  • Pfizer’s Weight Loss Drug Failure: Why This Game-Changing Market Just Got Wild
  • New dual-action drug produces 13% weight loss in people with type 2 diabetes
  • For People With Diabetes, GLP-1 Drugs May Be Linked to Lower Odds of a Leading Cause of Blindness
  • Greenwich Rx Recalls Injectable Glutathione Nationwide Over Bacterial Toxin Risk
  • New Class Of Weight-Loss Drugs May Have Fewer Side Effects Than GLP-1s

Recent Comments

No comments to show.

Recent Comments

    Archives

    • October 2026

    Categories

    • Compounding & Peptide Industry
    • Regulation & Policy
    • Research & Clinical Trials
    Copyright © 2026. All rights reserved. Theme Rubik News by Kantipur Themes